An-qing Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
DangGuiSiNi Decoction and QiShenYiQi Pills Ameliorate Hyperpermeability and Edema Induced by Cold Exposure.
Journal: Microcirculation (New York, N.Y. : 1994)
Published: June 23, 2026
Ginsenoside Rb1 alleviates isoproterenol- and transverse aortic constriction-induced cardiac fibrosis by suppressing monocyte recruitment via targeting Raf1.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 09, 2026
Anisodamine Hydrobromide Ameliorates Pulmonary Microcirculatory Dysfunction in Septic Rats.
Journal: Microcirculation (New York, N.Y. : 1994)
Published: December 08, 2025
Anisodine hydrobromide targets matk and prevents delayed rtPA thrombolysis-induced vasogenic cerebral edema in ischemic stroke.
Journal: Nature communications
Published: July 10, 2025
YangXue QingNao Wan ameliorates vascular dementia in 2-VO rats via inhibition of ferroptosis.
Journal: Journal of ethnopharmacology
Published: May 14, 2025
QiShenYiQi pills ameliorated aspirin and clopidogrel-induced gastric hemorrhage via multi-target regulation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 12, 2025
Angong Niuhuang Wan ameliorates LPS-induced cerebrovascular edema by inhibiting blood‒brain barrier leakage and promoting the membrane expression of AQP4.
Journal: Frontiers in pharmacology
Published: April 22, 2024
QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway.
Journal: Frontiers in pharmacology
Published: April 12, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026